Spain, Jan. 12 -- Spain based GILEAD SCIENCES S.L. has secured contract from HOSPITAL UNIVERSITARIO RAMON Y CAJAL for Antineoplastic agents - Acquisition of the drug TECRTUS 0.4-2 X10e8 cells dispersion for infusion. The value of the contract is worth 145442496 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....